Identification of domains responsible for specific membrane transport and ligand specificity of the ACTH receptor (MC2R)

Molecular and Cellular Endocrinology

Volumn 321, Issue 2, 2010, Pages 175-183

  Fridmanis, Davids ^a,b   Petrovska, Ramona ^a   Kalnina, Ineta ^a,b   Slaidina, Maija ^a,b   Peculis, Raitis ^a   Schiöth, Helgi ^b   Klovins, Janis ^a,b  

^a LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

ACTHR; Chimeric receptors; GFP; GPCR; Melanocortin; Membrane transport; MRAP; Rhodopsin

Indexed keywords

ALPHA INTERMEDIN; CYCLIC AMP; ENHANCED GREEN FLUORESCENT PROTEIN; MELANOCORTIN 2 RECEPTOR; PROTEIN DPHE7; PROTEIN NLE4; UNCLASSIFIED DRUG; CARRIER PROTEIN; FLUORESCENT DYE; LIGAND;

AMINO TERMINAL SEQUENCE; ARTICLE; CELLULAR DISTRIBUTION; CHIMERA; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIGAND BINDING; MEMBRANE TRANSPORT; MUTAGENESIS; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; QUANTITATIVE STUDY; RECEPTOR BINDING; SIGNAL TRANSDUCTION; CELL LINE; CHEMISTRY; ENZYME SPECIFICITY; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

CELL LINE; FLUORESCENT DYES; HUMANS; LIGANDS; MEMBRANE TRANSPORT PROTEINS; MICROSCOPY, CONFOCAL; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECEPTOR, MELANOCORTIN, TYPE 2; SUBSTRATE SPECIFICITY;

EID: 77951258541     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.02.032     Document Type: Article

References (64)

1. Abdel-Malek Z.A. Melanocortin receptors: their functions and regulation by physiological agonists and antagonists. Cell. Mol. Life Sci. 2001, 58(3):434-441.
2. Allolio B., Reincke M. Adrenocorticotropin receptor and adrenal disorders. Horm. Res. 1997, 47(4-6):273-278.
3. Argiolas A., Melis M.R., Murgia S., Schioth H.B. ACTH- and alpha-MSH-induced grooming, stretching, yawning and penile erection in male rats: site of action in the brain and role of melanocortin receptors. Brain Res. Bull. 2000, 51(5):425-431.
4. Boer U., Neuschafer-Rube F., Moller U., Puschel G.P. Requirement of N-glycosylation of the prostaglandin E2 receptor EP3beta for correct sorting to the plasma membrane but not for correct folding. Biochem. J. 2000, 350 Pt 3:839-847.
5. Boston B.A. The role of melanocortins in adipocyte function. Ann. N.Y. Acad. Sci. 1999, 885:75-84.
6. Butler A.A. The melanocortin system and energy balance. Peptides 2006, 27(2):281-290.
7. Chen W., Kelly M.A., Opitz-Araya X., Thomas R.E., Low M.J., Cone R.D. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 1997, 91(6):789-798.
8. Chhajlani V., Wikberg J.E. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 1992, 309(3):417-420.
9. Chida D, Nakagawa S., Nagai S., Sagara H., Katsumata H., Imaki T., Suzuki H., Mitani F., Ogishima T., Shimizu C., Kotaki H., Kakuta S., Sudo K., Koike T., Kubo M., Iwakura Y. Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis. Proc. Natl. Acad. Sci. U.S.A. 2007, 104(46):18205-18210.
10. Chung T.T., Webb T.R., Chan L.F., Cooray S.N., Metherell L.A., King P.J., Chapple J.P., Clark A.J. The majority of ACTH receptor (MC2R) mutations found in Familial Glucocorticoid Deficiency type 1 lead to defective trafficking of the receptor to the cell surface. J. Clin. Endocrinol. Metab. 2008.
11. Clark A.J, Cammas F.M. The ACTH receptor. Baillieres Clin. Endocrinol. Metab. 1996, 10(1):29-47.
12. Cooray S.N., Almiro Do Vale I., Leung K.Y., Webb T.R., Chapple J.P., Egertova M., Cheetham M.E., Elphick M.R., Clark A.J. The melanocortin 2 receptor accessory protein exists as a homodimer and is essential for the function of the melanocortin 2 receptor in the mouse y1 cell line. Endocrinology 2008, 149(4):1935-1941.
13. De Wied D., Jolles J. Neuropeptides derived from pro-opiocortin: behavioral, physiological, and neurochemical effects. Physiol. Rev. 1982, 62(3):976-1059.
14. Dunn O.J Multiple comparisons using rank sums. Technometrics 1964, 6:241-252.
15. Eberle A.N. Chem. Physiol. Mech. Action 1988.
16. Elias L.L., Huebner A., Pullinger G.D., Mirtella A., Clark A.J. Functional characterization of naturally occurring mutations of the human adrenocorticotropin receptor: poor correlation of phenotype and genotype. J. Clin. Endocrinol. Metab. 1999, 84(8):2766-2770.
17. Ellacott K.L., Cone R.D. The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis. Recent Prog. Horm. Res. 2004, 59:395-408.
18. Ellacott K.L., Murphy J.G., Marks D.L., Cone R.D. Obesity-induced inflammation in white adipose tissue is attenuated by loss of melanocortin-3 receptor signaling. Endocrinology 2007, 148(12):6186-6194.
19. Fan W., Morrison S.F., Cao W.H., Yu P. Thermogenesis activated by central melanocortin signaling is dependent on neurons in the rostral raphe pallidus (rRPa) area. Brain Res. 2007, 1179:61-69.
20. Fan W., Voss-Andreae A., Cao W.H., Morrison S.F. Regulation of thermogenesis by the central melanocortin system. Peptides 2005, 26(10):1800-1813.
21. Fredriksson R, Lagerstrom M.C., Lundin L.G., Schioth H.B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 2003, 63(6):1256-1272.
22. Frielle T., Daniel K.W., Caron M.G., Lefkowitz R.J. Structural basis of beta-adrenergic receptor subtype specificity studied with chimeric beta 1/beta 2-adrenergic receptors. Proc. Natl. Acad. Sci. U.S.A. 1988, 85(24):9494-9498.
23. Gantz I, Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G., Watson S.J., DelValle J., Yamada T. Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 1993, 268(11):8246-8250.
24. Gantz I., Miwa H., Konda Y., Shimoto Y., Tashiro T., Watson S.J., DelValle J., Yamada T. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem. 1993, 268(20):15174-15179.
25. Gantz I., Shimoto Y., Konda Y., Miwa H., Dickinson C.J., Yamada T. Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem. Biophys. Res. Commun. 1994, 200(3):1214-1220.
26. Gupta R, Brunak S. Prediction of glycosylation across the human proteome and the correlation to protein function. Pac. Symp. Biocomput. 2002, 310-322.
27. Gupta, R., Jung, E., Brunak, S., in preparation. Prediction of N-glycosylation sites in human proteins.
28. Haycock J.W, Wagner M., Morandini R., Ghanem G., Rennie I.G., MacNeil S. Alpha-MSH immunomodulation acts via rel/NF-kappa B in cutaneous and ocular melanocytes and in melanoma cells. Ann. N.Y. Acad. Sci. 1999, 885:396-399.
29. Ho S.N., Hunt H.D., Horton R.M., Pullen J.K., Pease L.R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989, 77(1):51-59.
30. Humphreys M.H Gamma-MSH, sodium metabolism, and salt-sensitive hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286(3):R417-R430.
31. Kobilka B.K., Kobilka T.S., Daniel K., Regan J.W., Caron M.G., Lefkowitz R.J. Chimeric alpha 2-, beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science 1988, 240(4857):1310-1316.
32. Konda Y, Gantz I., DelValle J., Shimoto Y., Miwa H., Yamada T. Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J. Biol. Chem. 1994, 269(18):13162-13166.
33. Kovalitskaia Yu A., Kolobov A.A., Kampe-Nemm E.A., Iurovskii V.V., Sadovnikov V.B., Lipkin V.M., Navolotskaia E.V. Synthetic peptide KKRR corresponding to the human ACTH fragment 15-18 is an antagonist of the ACTH receptor. Bioorg. Khim. 2008, 34(1):29-35.
34. Lagerstrom M.C, Klovins J., Fredriksson R., Fridmanis D., Haitina T., Ling M.K., Berglund M.M., Schioth H.B. High affinity agonistic metal ion binding sites within the melanocortin 4 receptor illustrate conformational change of transmembrane region 3. J. Biol. Chem. 2003, 278(51):51521-51526.
35. Lasaga M., Debeljuk L., Durand D., Scimonelli T.N., Caruso C. Role of alpha-melanocyte stimulating hormone and melanocortin 4 receptor in brain inflammation. Peptides 2008, 29(10):1825-1835.
36. Lu X.Y Role of central melanocortin signaling in eating disorders. Psychopharmacol. Bull. 2001, 35(4):45-65.
37. Metherell L.A., Chapple J.P., Cooray S., David A., Becker C., Ruschendorf F., Naville D., Begeot M., Khoo B., Nurnberg P., Huebner A., Cheetham M.E., Clark A.J. Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat. Genet. 2005, 37(2):166-170.
38. Mountjoy K.G, Robbins L.S., Mortrud M.T., Cone R.D. The cloning of a family of genes that encode the melanocortin receptors. Science 1992, 257(5074):1248-1251.
39. Naville D., Penhoat A., Durand P., Begeot M. Three steroidogenic factor-1 binding elements are required for constitutive and cAMP-regulated expression of the human adrenocorticotropin receptor gene. Biochem. Biophys. Res. Commun. 1999, 255(1):28-33.
40. Noon L.A, Franklin J.M., King P.J., Goulding N.J., Hunyady L., Clark A.J. Failed export of the adrenocorticotrophin receptor from the endoplasmic reticulum in non-adrenal cells: evidence in support of a requirement for a specific adrenal accessory factor. J. Endocrinol. 2002, 174(1):17-25.
41. Penhoat A., Jaillard C., Saez J.M. Corticotropin positively regulates its own receptors and cAMP response in cultured bovine adrenal cells. Proc. Natl. Acad. Sci. U.S.A. 1989, 86(13):4978-4981.
42. Penhoat A, Naville D., El Mourabit H., Buronfosse A., Berberoglu M., Ocal G., Tsigos C., Durand P., Begeot M. Functional relationships between three novel homozygous mutations in the ACTH receptor gene and familial glucocorticoid deficiency. J. Mol. Med. 2002, 80(7):406-411.
43. Petrecca K., Atanasiu R., Akhavan A., Shrier A. N-linked glycosylation sites determine HERG channel surface membrane expression. J. Physiol. 1999, 515(Pt 1):41-48.
44. Pfaus J.G, Shadiack A., Van Soest T., Tse M., Molinoff P. Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(27):10201-10204.
45. Rinne P., Harjunpaa J., Scheinin M., Savontaus E. Blood pressure regulation and cardiac autonomic control in mice overexpressing alpha- and gamma-melanocyte stimulating hormone. Peptides 2008, 29(11):1943-1952.
46. Roy S, Rached M., Gallo-Payet N. Differential regulation of the human adrenocorticotropin receptor [melanocortin-2 receptor (MC2R)] by human MC2R accessory protein isoforms alpha and beta in isogenic human embryonic kidney 293 cells. Mol. Endocrinol. 2007, 21(7):1656-1669.
47. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., Sturn A., Snuffin M., Rezantsev A., Popov D., Ryltsov A., Kostukovich E., Borisovsky I., Liu Z., Vinsavich A., Trush V., Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34(2):374-378.
48. Schimmer B.P, Kwan W.K., Tsao J., Qiu R. Adrenocorticotropin-resistant mutants of the Y1 adrenal cell line fail to express the adrenocorticotropin receptor. J. Cell. Physiol. 1995, 163(1):164-171.
49. Schioth H.B., Fredriksson A., Carlsson C., Yook P., Muceniece R., Wikberg J.E. Evidence indicating that the extracellular loops of the mouse MC5 receptor do not participate in ligand binding. Mol. Cell. Endocrinol. 1998, 139(1-2):109-115.
50. Schioth H.B., Muceniece R., Szardenings M., Prusis P., Wikberg J.E. Evidence indicating that the TM4, EL2, and TM5 of the melanocortin 3 receptor do not participate in ligand binding. Biochem. Biophys. Res. Commun. 1996, 229(3):687-692.
51. Schioth H.B., Yook P., Muceniece R., Wikberg J.E., Szardenings M. Chimeric melanocortin MC1 and MC3 receptors: identification of domains participating in binding of melanocyte-stimulating hormone peptides. Mol. Pharmacol. 1998, 54(1):154-161.
52. Sebag J.A., Hinkle P.M. Melanocortin-2 receptor accessory protein MRAP forms antiparallel homodimers. Proc. Natl. Acad. Sci. U.S.A. 2007, 104(51):20244-20249.
53. Sebag J.A, Hinkle P.M. Regions of melanocortin2 receptor accessory protein necessary for dual topology and MC2 receptor trafficking and signaling. J. Biol. Chem. 2008.
54. Shimozono S., Miyawaki A. Engineering FRET constructs using CFP and YFP. Methods Cell Biol. 2008, 85:381-393.
55. Simpson E.R., Waterman M.R. Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH. Annu. Rev. Physiol. 1988, 50:427-440.
56. Sina M., Hinney A., Ziegler A., Neupert T., Mayer H., Siegfried W., Blum W.F., Remschmidt H., Hebebrand J. Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene. Am. J. Hum. Genet. 1999, 65(6):1501-1507.
57. Spencer J.D, Schallreuter K.U. Regulation of pigmentation in human epidermal melanocytes by functional high affinity {beta}-MSH/MC4-R signalling. Endocrinology 2008.
58. Starowicz K., Przewlocka B. The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception. Life Sci. 2003, 73(7):823-847.
59. Theodoropoulou M.C, Bagos P.G., Spyropoulos I.C., Hamodrakas S.J. gpDB: a database of GPCRs, G-proteins, effectors and their interactions. Bioinformatics 2008, 24(12):1471-1472.
60. Thiboutot D., Sivarajah A., Gilliland K., Cong Z., Clawson G. The melanocortin 5 receptor is expressed in human sebaceous glands and rat preputial cells. J. Invest. Dermatol. 2000, 115(4):614-619.
61. Webb T.R., Chan L., Cooray S.N., Cheetham M.E., Chapple J.P., Clark A.J. Distinct MRAP domains are required for MC2R interaction and promotion of receptor trafficking. Endocrinology 2008.
62. Wessells H., Gralnek D., Dorr R., Hruby V.J., Hadley M.E., Levine N. Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction. Urology 2000, 56(4):641-646.
63. Williams G, Bing C., Cai X.J., Harrold J.A., King P.J., Liu X.H. The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol. Behav. 2001, 74(4-5):683-701.
64. Yeo G.S., Farooqi I.S., Challis B.G., Jackson R.S., O'Rahilly S. The role of melanocortin signalling in the control of body weight: evidence from human and murine genetic models. QJM 2000, 93(1):7-14.